We are excited to announce the addition of six accomplished professionals to our Board of Trustees. With diverse expertise spanning science, business, finance, governance, and patient advocacy, these new trustees bring a wealth of knowledge to PNRI’s mission of advancing groundbreaking genetic research.
“As PNRI continues to grow and expand its impact, having a strong, dynamic Board of Trustees is essential,” says Jack Faris, PhD, PNRI CEO. “This new group of trustees brings unparalleled expertise and dedication to our mission. Together, we’ll shape the future of genetic research and unlock solutions to some of the most pressing health challenges.”
Meet the New Trustees
